AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)

RecruitingNAAges 18 Years - anyAllBoston University Charles River Campus
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This cluster-randomized crossover trial evaluates whether the packaging format of small-quantity lipid-based nutrient supplements (SQ-LNS) affects caregiver adherence and acceptability when SQ-LNS are delivered through routine growth monitoring services in Northern Ghana. SQ-LNS are a proven intervention for reducing child malnutrition, but packaging format may affect how caregivers store, dispense, and use the product, and it also drives cost and distribution logistics. Up to sixteen health facilities participating in growth monitoring services each deliver both formats: a 1-day sachet (20 g daily) and a 7-day resealable pouch (140 g weekly), with the order of delivery randomized at facility level. Each format is delivered for one month before crossover, and caregivers receive a 28-day supply totaling 560 g in each period regardless of format. The primary outcome is adherence, measured

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * The caregiver is 18 years or older and is the primary caregiver of the child * The child is 6-24 months of age at the time of enrollment * The child is eligible to receive routine growth monitoring and promotion services at the participating clinic * The caregiver provides written informed consent to participate Exclusion Criteria: * The child has severe acute malnutrition (SAM) or medical complications requiring medication or inpatient care * The child has a known allergy to peanuts, milk, or other components of the supplement, or has a medical condition that prevents consumption of complementary foods * The caregiver or child is concurrently enrolled in another nutrition intervention study or clinical trial * The family plans to relocate outside the study area during the two-month follow-up * The caregiver is unwilling to provide informed consent or to follow the study procedures
๐Ÿ’Š

What it tests

  • small-quantity lipid-based nutrient supplements (SQ-LNS)
๐Ÿ“

Where

1 site
Ghana Health Service facilities, Kumbungu and Tolon Districts
Kumbungu, Ghana
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy